Clinical trial
Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China
NCT04572568 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 1, 2011
- Completion date
- April 1, 2033
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain arteriovenous malformation